Skip to main content
. 2020 Jan 28;7(3):973–983. doi: 10.1002/ehf2.12598

Figure 3.

Figure 3

Enrolled subjects (red) and enrolling sites (blue) over time since first patient in. Prognosis (grey line, pink shading) assumes constant rates of newly enrolling sites in the first year and newly enrolled subjects per site. The CAVA‐ADHF trial aims to enrol a total of 388 patients (dotted horizontal line), which is approximated to be reached within 26 months from the start of enrolment (dotted vertical line).